A cost-benefit analysis of preventive care: The case of breast cancer screening

Yu Ping Wen, Mei Ling Sheu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Use mammograms as an example to demonstrate the application and limitation of cost-benefit analysis on the preventive care policy of the National Health Insurance of Taiwan. Methods: Use the Cancer Report of the Department of Health (DOH), Disability-Adjusted Life Years (DALY) estimated by Lan and Liang , payment schedule of the Bureau of National Health Insurance (BNHI), and the methods of Maciosek et al. to estimate the benefits and costs of mammograms. Results: Cost-benefit analysis results suggest that a two-step screening strategy can effectively reduce costs and pass the cost-benefit test. High price, low sensitivity, and false positives tend to make it financially unworthy to indiscriminately screen for breast cancer in all women aged 50 to 69 by mammograms. Conclusions: Cost benefit analysis provides a framework for decision-making. Its strength lies in its systematic use of information, thus different opinions can be thoroughly discussed. While a full-scale mammogram does not currently pass the cost-benefit test, the analysis indicates that the expected benefits of screening can be increased through an increase in test sensitivity or a reduction in screening price. We recommend that policy-makers use cost-benefit analysis in the future to systematically examine the potential gains and losses of health care policies.

Original languageEnglish
Pages (from-to)519-528
Number of pages10
JournalTaiwan Journal of Public Health
Volume24
Issue number6
Publication statusPublished - Dec 2005

Fingerprint

Preventive Medicine
Early Detection of Cancer
Cost-Benefit Analysis
Breast Neoplasms
National Health Programs
Quality-Adjusted Life Years
Health Policy
Administrative Personnel
Taiwan
Decision Making
Appointments and Schedules
Delivery of Health Care
Costs and Cost Analysis
Health

Keywords

  • Breast cancer
  • Cost-benefit analysis
  • DALY
  • Prevention policy

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

A cost-benefit analysis of preventive care : The case of breast cancer screening. / Wen, Yu Ping; Sheu, Mei Ling.

In: Taiwan Journal of Public Health, Vol. 24, No. 6, 12.2005, p. 519-528.

Research output: Contribution to journalArticle

@article{7a720554d6fe461dafa72af141af0f40,
title = "A cost-benefit analysis of preventive care: The case of breast cancer screening",
abstract = "Objective: Use mammograms as an example to demonstrate the application and limitation of cost-benefit analysis on the preventive care policy of the National Health Insurance of Taiwan. Methods: Use the Cancer Report of the Department of Health (DOH), Disability-Adjusted Life Years (DALY) estimated by Lan and Liang , payment schedule of the Bureau of National Health Insurance (BNHI), and the methods of Maciosek et al. to estimate the benefits and costs of mammograms. Results: Cost-benefit analysis results suggest that a two-step screening strategy can effectively reduce costs and pass the cost-benefit test. High price, low sensitivity, and false positives tend to make it financially unworthy to indiscriminately screen for breast cancer in all women aged 50 to 69 by mammograms. Conclusions: Cost benefit analysis provides a framework for decision-making. Its strength lies in its systematic use of information, thus different opinions can be thoroughly discussed. While a full-scale mammogram does not currently pass the cost-benefit test, the analysis indicates that the expected benefits of screening can be increased through an increase in test sensitivity or a reduction in screening price. We recommend that policy-makers use cost-benefit analysis in the future to systematically examine the potential gains and losses of health care policies.",
keywords = "Breast cancer, Cost-benefit analysis, DALY, Prevention policy",
author = "Wen, {Yu Ping} and Sheu, {Mei Ling}",
year = "2005",
month = "12",
language = "English",
volume = "24",
pages = "519--528",
journal = "台灣公共衛生雜誌",
issn = "1023-2141",
publisher = "臺灣公共衛生學會",
number = "6",

}

TY - JOUR

T1 - A cost-benefit analysis of preventive care

T2 - The case of breast cancer screening

AU - Wen, Yu Ping

AU - Sheu, Mei Ling

PY - 2005/12

Y1 - 2005/12

N2 - Objective: Use mammograms as an example to demonstrate the application and limitation of cost-benefit analysis on the preventive care policy of the National Health Insurance of Taiwan. Methods: Use the Cancer Report of the Department of Health (DOH), Disability-Adjusted Life Years (DALY) estimated by Lan and Liang , payment schedule of the Bureau of National Health Insurance (BNHI), and the methods of Maciosek et al. to estimate the benefits and costs of mammograms. Results: Cost-benefit analysis results suggest that a two-step screening strategy can effectively reduce costs and pass the cost-benefit test. High price, low sensitivity, and false positives tend to make it financially unworthy to indiscriminately screen for breast cancer in all women aged 50 to 69 by mammograms. Conclusions: Cost benefit analysis provides a framework for decision-making. Its strength lies in its systematic use of information, thus different opinions can be thoroughly discussed. While a full-scale mammogram does not currently pass the cost-benefit test, the analysis indicates that the expected benefits of screening can be increased through an increase in test sensitivity or a reduction in screening price. We recommend that policy-makers use cost-benefit analysis in the future to systematically examine the potential gains and losses of health care policies.

AB - Objective: Use mammograms as an example to demonstrate the application and limitation of cost-benefit analysis on the preventive care policy of the National Health Insurance of Taiwan. Methods: Use the Cancer Report of the Department of Health (DOH), Disability-Adjusted Life Years (DALY) estimated by Lan and Liang , payment schedule of the Bureau of National Health Insurance (BNHI), and the methods of Maciosek et al. to estimate the benefits and costs of mammograms. Results: Cost-benefit analysis results suggest that a two-step screening strategy can effectively reduce costs and pass the cost-benefit test. High price, low sensitivity, and false positives tend to make it financially unworthy to indiscriminately screen for breast cancer in all women aged 50 to 69 by mammograms. Conclusions: Cost benefit analysis provides a framework for decision-making. Its strength lies in its systematic use of information, thus different opinions can be thoroughly discussed. While a full-scale mammogram does not currently pass the cost-benefit test, the analysis indicates that the expected benefits of screening can be increased through an increase in test sensitivity or a reduction in screening price. We recommend that policy-makers use cost-benefit analysis in the future to systematically examine the potential gains and losses of health care policies.

KW - Breast cancer

KW - Cost-benefit analysis

KW - DALY

KW - Prevention policy

UR - http://www.scopus.com/inward/record.url?scp=33344470237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33344470237&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33344470237

VL - 24

SP - 519

EP - 528

JO - 台灣公共衛生雜誌

JF - 台灣公共衛生雜誌

SN - 1023-2141

IS - 6

ER -